Nephrology

Your Article Summary

See Latest Articles

Soluble CD40 Ligand, Plasminogen Activator Inhibitor-1 and Thrombin-Activatable Fibrinolysis Inhibitor-1-Antigen in Normotensive Type 2 Diabetic Subjects without Diabetic Complications
Medical Principles and Practice, 06/03/09

Yener S et al. - The results showed that nonobese diabetic patients at low cardiovascular risk had similar levels of subclinical markers of inflammation and fibrinolysis as matched healthy controls. Neither metformin nor rosiglitazone caused marked changes in sCD40L, PAI-1 and TAFI antigen levels. A subset of patients who received simvastatin showed a modest decrease in PAI-1 level and could contribute to beneficial vasculoprotective effect of the drug in type 2 diabetics.

Today in Endocrinology...keeping you current

Receive free subspecialty "5-minute updates" via email

Eosinophil Count Is Positively Correlated with Albumin Excretion Rate in Men with Type 2 Diabetes
Clinical Journal of the American Society of Nephrology, 11/05/09

Does Diabetes Mellitus Predispose to Increased Fluid Overload in Peritoneal Dialysis Patients
Nephron: Clinical Practice, 10/12/09

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria
Kidney International, 10/27/09

See All of Endocrinology

Today in Hypertension...keeping you current

Receive free subspecialty "5-minute updates" via email

A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
The Lancet, 10/27/09

Obesity-Related Cardiorenal Syndrome
The Journal of Clinical Hypertension, 10/20/09

Practical strategies for management of hypertension in the elderly
Geriatrics, 10/21/09

See All of Hypertension